201 related articles for article (PubMed ID: 11336438)
1. Pharmacologic inhibition of poly(ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats.
LaPlaca MC; Zhang J; Raghupathi R; Li JH; Smith F; Bareyre FM; Snyder SH; Graham DI; McIntosh TK
J Neurotrauma; 2001 Apr; 18(4):369-76. PubMed ID: 11336438
[TBL] [Abstract][Full Text] [Related]
2. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
[TBL] [Abstract][Full Text] [Related]
3. Detection of single- and double-strand DNA breaks after traumatic brain injury in rats: comparison of in situ labeling techniques using DNA polymerase I, the Klenow fragment of DNA polymerase I, and terminal deoxynucleotidyl transferase.
Clark RSB ; Chen M; Kochanek PM; Watkins SC; Jin KL; Draviam R; Nathaniel PD; Pinto R; Marion DW; Graham SH
J Neurotrauma; 2001 Jul; 18(7):675-89. PubMed ID: 11497094
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat.
Kabra DG; Thiyagarajan M; Kaul CL; Sharma SS
Brain Res Bull; 2004 Feb; 62(5):425-33. PubMed ID: 15168908
[TBL] [Abstract][Full Text] [Related]
5. Poly (ADP-ribose) polymerase-1: an emerging target in right ventricle dysfunction associated with pulmonary hypertension.
Kaur G; Singh N; Lingeshwar P; Siddiqui HH; Hanif K
Pulm Pharmacol Ther; 2015 Feb; 30():66-79. PubMed ID: 25481773
[TBL] [Abstract][Full Text] [Related]
6. Temporal patterns of poly(ADP-ribose) polymerase activation in the cortex following experimental brain injury in the rat.
LaPlaca MC; Raghupathi R; Verma A; Pieper AA; Saatman KE; Snyder SH; McIntosh TK
J Neurochem; 1999 Jul; 73(1):205-13. PubMed ID: 10386972
[TBL] [Abstract][Full Text] [Related]
7. Mild traumatic brain injury induces apoptotic cell death in the cortex that is preceded by decreases in cellular Bcl-2 immunoreactivity.
Raghupathi R; Conti AC; Graham DI; Krajewski S; Reed JC; Grady MS; Trojanowski JQ; McIntosh TK
Neuroscience; 2002; 110(4):605-16. PubMed ID: 11934469
[TBL] [Abstract][Full Text] [Related]
8. Riluzole, a novel neuroprotective agent, attenuates both neurologic motor and cognitive dysfunction following experimental brain injury in the rat.
McIntosh TK; Smith DH; Voddi M; Perri BR; Stutzmann JM
J Neurotrauma; 1996 Dec; 13(12):767-80. PubMed ID: 9002062
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical increase in neuronal DNA fragmentation after neuroprotective free radical scavenger treatment in experimental traumatic brain injury.
Lewén A; Skoglösa Y; Clausen F; Marklund N; Chan PH; Lindholm D; Hillered L
J Cereb Blood Flow Metab; 2001 Apr; 21(4):344-50. PubMed ID: 11323520
[TBL] [Abstract][Full Text] [Related]
10. Effect of acute poly(ADP-ribose) polymerase inhibition by 3-AB on blood-brain barrier permeability and edema formation after focal traumatic brain injury in rats.
Lescot T; Fulla-Oller L; Palmier B; Po C; Beziaud T; Puybasset L; Plotkine M; Gillet B; Meric P; Marchand-Leroux C
J Neurotrauma; 2010 Jun; 27(6):1069-79. PubMed ID: 20380552
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of PJ34 and INO-1001, two novel water-soluble poly(ADP-ribose) polymerase inhibitors, on the consequences of traumatic brain injury in rat.
Besson VC; Zsengellér Z; Plotkine M; Szabó C; Marchand-Verrecchia C
Brain Res; 2005 Apr; 1041(2):149-56. PubMed ID: 15829224
[TBL] [Abstract][Full Text] [Related]
12. GPI 6150 prevents H(2)O(2) cytotoxicity by inhibiting poly(ADP-ribose) polymerase.
Zhang J; Lautar S; Huang S; Ramsey C; Cheung A; Li JH
Biochem Biophys Res Commun; 2000 Nov; 278(3):590-8. PubMed ID: 11095954
[TBL] [Abstract][Full Text] [Related]
13. A molecular basis for the efficacy of magnesium treatment following traumatic brain injury in rats.
Lee JS; Han YM; Yoo DS; Choi SJ; Choi BH; Kim JH; Kim YH; Huh PW; Ko YJ; Rha HK; Cho KS; Kim DS
J Neurotrauma; 2004 May; 21(5):549-61. PubMed ID: 15165363
[TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-ribose) polymerase inhibition improves endothelial dysfunction induced by reactive oxidant hydrogen peroxide in vitro.
Radovits T; Lin LN; Zotkina J; Gero D; Szabó C; Karck M; Szabó G
Eur J Pharmacol; 2007 Jun; 564(1-3):158-66. PubMed ID: 17397824
[TBL] [Abstract][Full Text] [Related]
15. Local administration of the poly(ADP-ribose) polymerase inhibitor INO-1001 prevents NAD+ depletion and improves water maze performance after traumatic brain injury in mice.
Clark RS; Vagni VA; Nathaniel PD; Jenkins LW; Dixon CE; Szabó C
J Neurotrauma; 2007 Aug; 24(8):1399-405. PubMed ID: 17711401
[TBL] [Abstract][Full Text] [Related]
16. Poly(ADP-ribose) polymerase inhibition by cilostazol is implicated in the neuroprotective effect against focal cerebral ischemic infarct in rat.
Lee JH; Park SY; Shin HK; Kim CD; Lee WS; Hong KW
Brain Res; 2007 Jun; 1152():182-90. PubMed ID: 17433265
[TBL] [Abstract][Full Text] [Related]
17. The effects of nicotinamide on apoptosis and blood-brain barrier breakdown following traumatic brain injury.
Hoane MR; Kaplan SA; Ellis AL
Brain Res; 2006 Dec; 1125(1):185-93. PubMed ID: 17109832
[TBL] [Abstract][Full Text] [Related]
18. Sequential pharmacotherapy with magnesium chloride and basic fibroblast growth factor after fluid percussion brain injury results in less neuromotor efficacy than that achieved with magnesium alone.
Guluma KZ; Saatman KE; Brown A; Raghupathi R; McIntosh TK
J Neurotrauma; 1999 Apr; 16(4):311-21. PubMed ID: 10225217
[TBL] [Abstract][Full Text] [Related]
19. The effects of α-lipoic acid on immature rats with traumatic brain injury.
Ozbal S; Cankurt U; Tugyan K; Pekcetin C; Sisman AR; Gunduz K; Micili SC
Biotech Histochem; 2015 Apr; 90(3):206-15. PubMed ID: 25420894
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma.
Genovese T; Mazzon E; Muià C; Patel NS; Threadgill MD; Bramanti P; De Sarro A; Thiemermann C; Cuzzocrea S
J Pharmacol Exp Ther; 2005 Feb; 312(2):449-57. PubMed ID: 15452194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
